alexa Traditional Herbal Formula Yueju Pill Demonstrates Features Of Next-generation Antidepressants With Novel Mechanisms
ISSN: 2327-5162

Alternative & Integrative Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

7th International Conference on Ayurveda, Homeopathy and Chinese Medicine
May 18-19, 2017 Munich, Germany

Gang Chen
Nanjing University of Chinese Medicine, China
ScientificTracks Abstracts: Altern Integr Med
DOI: 10.4172/2327-5162-C1-023
Yueju pill is a Traditional Chinese Medicine (TCM) which consists of five herbs, formulated to treat depression-related syndromes 800 years ago. Yueju is still widely prescribed to treat various conditions, including digestive dysfunctions and depression. Recently, we found that Yueju pill promotes fast-onset antidepressant-like efficacy in clinical and preclinical studies. As conventional antidepressants have a major disadvantage in delayed onset for depression treatment, the novel findings of Yueju’s unique rapid antidepressant efficacy and underlying mechanisms are of great significance both clinically and scientifically, such as prevention of suicide and uncovering novel neurobiological mechanisms of antidepressant activity. In preclinical studies, a single dose of Yueju rapidly attenuates the depression-like symptoms in various animal models and the antidepressant effects could last even longer than ketamine, the prototype fast-acting antidepressant with adverse behavioral and neurotoxic potential. We also revealed the critical neuromolecular mechanisms involving improved neural plasticity by Yueju. Moreover, Yueju targeted more therapeutic sites, and the activation of PKA-CREB-BDNF signaling pathway underlies the strain-dependent differences in the lasting antidepressant effects. Yueju was also effective in a novel model of treatment-resistant postpartum depression. Importantly, a clinical pilot study supported its fast-onset antidepressant efficacy. Our study also displayed that the Gardenia jasminoids Ellis (Zhi Zi) plays the primary role in the rapid antidepressant effects of Yueju and identified the effective fractions and candidate compounds. This line of studies suggests the classic TCM formula is invaluable therapeutic treatment for depression and may be used for treatment of the treatment-resistant depression.

Gang Chen is the Head of Center for Translational Systems Biology and Neuroscience and Director of the Key Laboratory of TCM for Brain Diseases at Nanjing University of Chinese Medicine. He obtained his PhD in Psychology at Rutgers University in 2004. Since the time he was appointed as the Jiangsu Distinguished Professor in 2012, he has established a cutting-edge lab to decipher the scientific basis by which TCM treats complex brain disorders, using multidisciplinary approaches, particularly the neurobiological, systems biological, phytomedicine and modern quantitative genetics technologies. His team has published more than 16 papers on treatment of depression using TCM herbal formula and/or bioactive ingredients in international journals, including 3 in Scientific Reports. He is currently the Committee Member of International Brain and Behavior Genetic Society (IBANGS) and has been invited to talk and chair in many international scientific conferences.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version